GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cardiovascular Systems Inc (FRA:R7Y1) » Definitions » Cyclically Adjusted PB Ratio

Cardiovascular Systems (FRA:R7Y1) Cyclically Adjusted PB Ratio : (As of May. 25, 2024)


View and export this data going back to 2012. Start your Free Trial

What is Cardiovascular Systems Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Cardiovascular Systems Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Cardiovascular Systems's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cardiovascular Systems Cyclically Adjusted PB Ratio Chart

Cardiovascular Systems Annual Data
Trend Jun13 Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Cardiovascular Systems Quarterly Data
Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Cardiovascular Systems's Cyclically Adjusted PB Ratio

For the Medical Devices subindustry, Cardiovascular Systems's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cardiovascular Systems's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Cardiovascular Systems's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Cardiovascular Systems's Cyclically Adjusted PB Ratio falls into.



Cardiovascular Systems Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Cardiovascular Systems's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2022 is calculated as:

For example, Cardiovascular Systems's adjusted Book Value per Share data for the three months ended in Dec. 2022 was:

Adj_Book=Book Value per Share/CPI of Dec. 2022 (Change)*Current CPI (Dec. 2022)
=5.385/125.2218*125.2218
=5.385

Current CPI (Dec. 2022) = 125.2218.

Cardiovascular Systems Quarterly Data

Book Value per Share CPI Adj_Book
201303 2.255 98.209 2.875
201306 2.078 98.518 2.641
201309 1.936 98.790 2.454
201312 3.826 98.326 4.873
201403 3.660 99.695 4.597
201406 3.600 100.560 4.483
201409 3.662 100.428 4.566
201412 3.806 99.070 4.811
201503 4.159 99.621 5.228
201506 3.895 100.684 4.844
201509 3.587 100.392 4.474
201512 3.401 99.792 4.268
201603 2.796 100.470 3.485
201606 2.738 101.688 3.372
201609 2.776 101.861 3.413
201612 3.261 101.863 4.009
201703 3.244 102.862 3.949
201706 3.208 103.349 3.887
201709 2.952 104.136 3.550
201712 3.154 104.011 3.797
201803 3.084 105.290 3.668
201806 3.450 106.317 4.063
201809 3.309 106.507 3.890
201812 3.498 105.998 4.132
201903 3.598 107.251 4.201
201906 3.748 108.070 4.343
201909 3.665 108.329 4.237
201912 3.659 108.420 4.226
202003 3.673 108.902 4.223
202006 6.016 108.767 6.926
202009 5.679 109.815 6.476
202012 5.600 109.897 6.381
202103 5.657 111.754 6.339
202106 5.592 114.631 6.109
202109 5.513 115.734 5.965
202112 5.658 117.630 6.023
202203 5.644 121.301 5.826
202206 5.761 125.017 5.770
202209 5.838 125.227 5.838
202212 5.385 125.222 5.385

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Cardiovascular Systems  (FRA:R7Y1) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Cardiovascular Systems Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Cardiovascular Systems's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Cardiovascular Systems (FRA:R7Y1) Business Description

Traded in Other Exchanges
N/A
Address
1225 Old Highway 8 Northwest, Saint Paul, MN, USA, 55112-6416
Cardiovascular Systems Inc is a medical technology company focused on patients with peripheral and coronary artery diseases. Its peripheral artery disease systems are catheter-based platforms used to treat plaque in leg arteries above and below the knee. The firm's orbital atherectomy systems are used in peripheral and coronary commercial applications. Its OAS products include the Diamondback 360 Peripheral and Stealth 360 systems. Sales of Peripheral OAS contribute the majority of revenue. Cardiovascular systems generate the vast majority of its revenue in the United States.

Cardiovascular Systems (FRA:R7Y1) Headlines

No Headlines